GenMark Diagnostics ROA 2010-2018 | GNMK

Current and historical return on assets (ROA) values for GenMark Diagnostics (GNMK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. GenMark Diagnostics ROA for the three months ending September 30, 2018 was -50.74%.
GenMark Diagnostics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.05B $0.09B -51.18%
2018-06-30 $-0.06B $0.10B -50.43%
2018-03-31 $-0.06B $0.11B -46.46%
2017-12-31 $-0.06B $0.12B -53.80%
2017-09-30 $-0.06B $0.13B -57.28%
2017-06-30 $-0.06B $0.15B -60.64%
2017-03-31 $-0.05B $0.06B -70.99%
2016-12-31 $-0.05B $0.08B -70.34%
2016-09-30 $-0.05B $0.09B -66.90%
2016-06-30 $-0.05B $0.06B -67.65%
2016-03-31 $-0.05B $0.06B -61.43%
2015-12-31 $-0.04B $0.07B -51.85%
2015-09-30 $-0.04B $0.08B -48.70%
2015-06-30 $-0.04B $0.08B -44.81%
2015-03-31 $-0.04B $0.09B -41.13%
2014-12-31 $-0.04B $0.09B -37.96%
2014-09-30 $-0.04B $0.10B -37.19%
2014-06-30 $-0.04B $0.11B -35.59%
2014-03-31 $-0.04B $0.11B -36.97%
2013-12-31 $-0.03B $0.12B -36.56%
2013-09-30 $-0.03B $0.13B -35.22%
2013-06-30 $-0.02B $0.06B -35.66%
2013-03-31 $-0.02B $0.06B -30.55%
2012-12-31 $-0.02B $0.07B -37.86%
2012-09-30 $-0.02B $0.07B -43.19%
2012-06-30 $-0.02B $0.07B -48.94%
2012-03-31 $-0.02B $0.03B -55.76%
2011-12-31 $-0.02B $0.04B -61.94%
2011-09-30 $-0.02B $0.04B -64.79%
2011-06-30 $-0.02B $0.05B -69.84%
2011-03-31 $-0.02B $0.02B -77.78%
2010-12-31 $-0.02B $0.03B -88.37%
2010-09-30 $-0.02B $0.03B -137.70%
2010-06-30 $-0.02B $0.03B -266.67%
2010-03-31 $-0.02B $0.00B inf%
2009-12-31 $-0.02B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.340B $0.053B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $99.090B 22.14
Intuitive Surgical (ISRG) United States $61.375B 57.77
Edwards Lifesciences (EW) United States $36.818B 37.47
Fresenius Medical Care AG KGaA (FMS) Germany $23.351B 15.79
IDEXX Laboratories (IDXX) United States $17.845B 48.46
ABIOMED (ABMD) United States $16.133B 106.49
Hologic (HOLX) United States $13.176B 19.92
DexCom (DXCM) United States $13.134B 0.00
Teleflex (TFX) United States $12.945B 29.39
Varian Medical Systems (VAR) United States $11.962B 29.88
STERIS (STE) United Kingdom $10.238B 26.31
Masimo (MASI) United States $6.826B 44.26
Penumbra (PEN) United States $5.298B 319.88
Globus Medical (GMED) United States $4.618B 28.94
LivaNova (LIVN) United Kingdom $4.597B 29.51
Integra LifeSciences Holdings (IART) United States $4.314B 21.02
Wright Medical Group (WMGI) Netherlands $3.921B 0.00
Cantel Medical (CMD) United States $3.443B 33.96
Inogen (INGN) United States $2.952B 63.71
Tandem Diabetes Care (TNDM) United States $2.827B 0.00
Integer Holdings (ITGR) United States $2.611B 21.85
Glaukos (GKOS) United States $2.400B 0.00
AVANOS MEDICAL, INC (AVNS) United States $2.244B 20.22
OPKO Health (OPK) United States $1.636B 0.00
Nevro (NVRO) United States $1.476B 0.00
Tactile Systems Technology (TCMD) United States $1.283B 204.24
ORTHOFIX MEDICAL INC (OFIX) United States $1.205B 34.81
Luminex (LMNX) United States $1.138B 52.10
Pacific Biosciences Of California (PACB) United States $1.059B 0.00
Accelerate Diagnostics (AXDX) United States $1.038B 0.00
Intersect ENT (XENT) United States $0.992B 0.00
CryoLife (CRY) United States $0.956B 103.40
Natus Medical (BABY) United States $0.904B 18.85
Mesa Laboratories (MLAB) United States $0.894B 36.57
AngioDynamics (ANGO) United States $0.860B 27.89
ViewRay (VRAY) United States $0.752B 0.00
Veracyte (VCYT) United States $0.730B 0.00
AxoGen (AXGN) United States $0.687B 0.00
Quotient (QTNT) Switzerland $0.652B 0.00
TransEnterix (TRXC) United States $0.586B 0.00
OrthoPediatrics (KIDS) United States $0.458B 0.00
Si-Bone (SIBN) United States $0.441B 0.00
Accuray (ARAY) United States $0.423B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.406B 0.00
Fluidigm (FLDM) United States $0.405B 0.00
Pulse Biosciences (PLSE) United States $0.373B 0.00
IRadimed (IRMD) United States $0.307B 65.35
Neuronetics (STIM) United States $0.306B 0.00
Sientra (SIEN) United States $0.301B 0.00
SeaSpine Holdings (SPNE) United States $0.294B 0.00
RTI Surgical (RTIX) United States $0.290B 46.50
Nuvectra (NVTR) United States $0.245B 0.00
Corindus Vascular Robotics (CVRS) United States $0.235B 0.00
CRH Medical (CRHM) Canada $0.235B 40.88
Helius Medical Technologies (HSDT) United States $0.171B 0.00
T2 Biosystems (TTOO) United States $0.156B 0.00
Ekso Bionics Holdings (EKSO) United States $0.137B 0.00
Sensus Healthcare (SRTS) United States $0.125B 0.00
Ra Medical Systems (RMED) United States $0.088B 0.00
Titan Medical (TMDI) Canada $0.085B 0.00
EDAP TMS (EDAP) France $0.082B 0.00
Biosig Technologies (BSGM) United States $0.075B 0.00
Apollo Endosurgery (APEN) United States $0.072B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.066B 0.00
ConforMIS (CFMS) United States $0.063B 0.00
Alphatec Holdings (ATEC) United States $0.061B 0.00
Vermillion (VRML) United States $0.059B 0.00
Second Sight Medical Products (EYES) United States $0.056B 0.00
Electromed (ELMD) United States $0.049B 25.43
OBALON THERPTCS (OBLN) United States $0.048B 0.00
Xtant Medical Holdings (XTNT) United States $0.038B 0.00
Microbot Medical (MBOT) United States $0.038B 0.00
Viveve Medical (VIVE) United States $0.033B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.032B 0.00
Restoration Robotics (HAIR) United States $0.032B 0.00
PAVmed (PAVM) United States $0.027B 0.00
DarioHealth (DRIO) Israel $0.025B 0.00
Lianluo Smart (LLIT) China $0.024B 0.00
Neovasc (NVCN) Canada $0.019B 0.00
Dynatronics (DYNT) United States $0.017B 0.00
American Shared Hospital Services (AMS) United States $0.014B 11.00
Bioanalytical Systems (BASI) United States $0.014B 45.67
ENDRA Life Sciences (NDRA) United States $0.013B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
ReWalk Robotics (RWLK) Israel $0.011B 0.00
Avinger (AVGR) United States $0.010B 0.00
Presbia (LENS) Ireland $0.009B 0.00
Atossa Genetics (ATOS) United States $0.009B 0.00
InspireMD (NSPR) Israel $0.008B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00